accountafter overcoming problems with a seed strain of the H1N1 virus. GlaxoSmithKline Plc is in discussions with the Food and Drug Administration about providing 7.6 million doses, Dr. Lurie said, adding that the talks had not slowed overall vaccine...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Senators Question U.S. Response to Flu
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
